ImaginAb Competitors and Similar CompaniesClear all
ImaginAb's competitors and similar companies include Dr Lal PathLabs, Mesoblast and ImmusanT.
 ImaginAb ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins. |  Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. |  Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. |  ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | |
Founding Date | Founding Date 2007 | Founding Date 1949 | Founding Date 2004 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Inglewood, US HQ Bracknell, GB | Locations Gurugram, IN HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Cambridge, US HQ |
Employees | Employees 195% decrease | Employees 4,099 | Employees 73 | Employees 2 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹27.6b (FY, 2026) | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ₹5.3b (FY, 2026) | Cost of goods $1.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ₹23.3b (FY, 2026) | Gross profit $16.1m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ₹5.1b (FY, 2026) | Net income ($102.1m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 46.8m | Total funding raised N/A | Total funding raised $ 56.2m | Total funding raised $ 72.8m |
For sources of this data, please see the company profile
View Company Profiles
Dr Lal PathLabs
HQ
Gurugram, IN
Employees
4,099
Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests.
View companyMesoblast
HQ
Melbourne, AU
Employees
73
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View companyImmusanT
HQ
Cambridge, US
Employees
2
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View company